These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10622088)

  • 21. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J; Sibley JT; Haga M
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Famotidine in the treatment of gastropathy induced by non-steroidal antirheumatic agents].
    Rybár I; Rovenský J; Hyrdel R
    Vnitr Lek; 1997 Apr; 43(4):208-10. PubMed ID: 9601836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of famotidine in the healing of active benign gastric ulceration: comparison of nonsteroidal anti-inflammatory- or aspirin-induced gastric ulcer and idiopathic gastric ulceration. Long Island Jewish Medical Center Acid-Peptic Study Group.
    Bank S; Blumstein M; Greenberg RE; Magier D; Lavin PT
    Clin Ther; 1993; 15(1):36-45. PubMed ID: 8458053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Graham DY
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992333
    [No Abstract]   [Full Text] [Related]  

  • 32. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drug to prevent NSAID-related ulcers.
    Liss GM
    CMAJ; 1996 Oct; 155(8):1043. PubMed ID: 8873631
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M; Sainaghi M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs].
    Lazebnik LB; Drozdov VN; Kim VA
    Eksp Klin Gastroenterol; 2009; (2):3-9. PubMed ID: 19552017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Steen KS; Lems WF; Dijkmans BA
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB; Phillips BB
    Ann Pharmacother; 2004 Sep; 38(9):1469-81. PubMed ID: 15213313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE; Murav'ev IuV; Nasonova VA
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs].
    Maev IV; V'iuchnova ES; Staseva IV
    Ter Arkh; 2004; 76(2):27-30. PubMed ID: 15106410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.